A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks by Jeong, YD, Ejima, K, Kim, KS, Iwanami, S, Hart, WS, Thompson, RN, Jung, IH, Iwami, S, Aihara, K

A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks by Jeong, YD, Ejima, K, Kim, KS, Iwanami, S, Hart, WS, Thompson, RN, Jung, IH, Iwami, S, Ajelli, M, Aihara, K

Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution by Sunagawa, J, Park, H, Kim, KS, Komorizono, R, Choi, S, Torres, LR, Woo, J, Jeong, YD, Hart, W, Thompson, R, Aihara, K, Iwami, S, Yamaguchi, S

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 by Kim, KS, Ejima, K, Iwanami, S, Fujita, Y, Ohashi, H, Koizumi, Y, Asai, Y, Nakaoka, S, Watashi, K, Aihara, K, Thompson, RN, Ke, R, Perelson, AS, Iwami, S

Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients by Takemura M, Mitsui K, Ido M, Matsumoto M, Koyama M, Inoue D, Takamatsu K, Itotani R, Ishitoko M, Suzuki S, Aihara K, Sakuramoto M, Kagioka H, Fukui M

Get full text

Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension by Yagi S, Takashima A, Mitsugi M, Wada T, Hotchi J, Aihara K, Hara T, Ishida M, Fukuda D, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M

Get full text

Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profiles by Jeong, YD, Hart, W, Thompson, R, Ishikane, M, Nishiyama, T, Park, H, Iwamoto, N, Sakurai, A, Suzuki, M, Aihara, K, Watashi, K, Op de Coul, E, Ohmagari, N, Wallinga, J, Iwami, S, Miura, F

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: a modeling study by Iwanami, S, Ejima, K, Kim, KS, Noshita, K, Fujita, Y, Miyazaki, T, Kohno, S, Miyazaki, Y, Morimoto, S, Nakaoka, S, Koizumi, Y, Asai, Y, Aihara, K, Watashi, K, Thompson, RN, Shibuya, K, Fujiu, K, Perelson, AS, Iwami, S, Wakita, T

Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers by Kim, KS, Iwamoto, M, Kitagawa, K, Park, H, Hayashi, S, Tsukuda, S, Matsui, T, Atsukawa, M, Matsuura, K, Chuaypen, N, Tangkijvanich, P, Allweiss, L, Nishiyama, T, Nakamura, N, Fujita, Y, Kawakami, E, Nakaoka, S, Muramatsu, M, Aihara, K, Wakita, T, Perelson, AS, Dandri, M, Watashi, K, Iwami, S

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment by Ohashi, H, Watashi, K, Saso, W, Shionoya, K, Iwanami, S, Hirokawa, T, Shirai, T, Kanaya, S, Ito, Y, Kim, KS, Nomura, T, Suzuki, T, Nishioka, K, Ando, S, Ejima, K, Koizumi, Y, Tanaka, T, Aoki, S, Kuramochi, K, Suzuki, T, Hashiguchi, T, Maenaka, K, Matano, T, Muramatsu, M, Saijo, M, Aihara, K, Iwami, S, Takeda, M, McKeating, JA, Wakita, T